VistaGen Therapeutics (VSTA) Highlighted at Chardan Capital After Allergan Acquires Comp Naurex
Go back to VistaGen Therapeutics (VSTA) Highlighted at Chardan Capital After Allergan Acquires Comp Naurex| Allergan Inc (NYSE: AGN) | Delayed: 193.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $193.02 | 52 Week High | $322.68 | |||
| Open | $15.33 | 52 Week Low | $186.34 | |||
| Day High | $193.02 | P/E | 45.96 | |||
| Day Low | $193.02 | EPS | $4.20 | |||
| Volume | 43,377 | |||||
| VistaGen Therapeutics, Inc. (NASDAQ: VSTA) | Delayed: 4.90 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.90 | 52 Week High | $16.50 | |||
| Open | $4.90 | 52 Week Low | $4.00 | |||
| Day High | $4.90 | P/E | N/A | |||
| Day Low | $4.90 | EPS | $-0.72 | |||
| Volume | 2,276,604 | |||||

